Scarica l'app Stockscreener
1.91
3.05%
-0.06
Dopo l'orario di chiusura:
1.95
0.04
+2.09%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$1.97
Aprire:
$1.95
Volume 24 ore:
261.57K
Relative Volume:
0.06
Capitalizzazione di mercato:
$16.14M
Reddito:
-
Utile/perdita netta:
$-19.92M
Rapporto P/E:
-0.4471
EPS:
-4.2716
Flusso di cassa netto:
$-20.51M
1 W Prestazione:
-5.91%
1M Prestazione:
+73.64%
6M Prestazione:
+39.42%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$1.89
$1.99
Intervallo di 1 settimana:
$1.89
$2.20
Portata 52W:
$0.82
$3.79
Biovie Inc Stock (BIVI) Company Profile
Nome
Biovie Inc
Settore
Industria
Telefono
775-888-3162
Indirizzo
680 W NYE LANE, CARSON CITY
Compare BIVI vs VRTX, REGN, ARGX, MRNA, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BIVI
Biovie Inc
|
1.91 | 16.65M | 0 | -19.92M | -20.51M | -4.2716 |
VRTX
Vertex Pharmaceuticals Inc
|
514.56 | 132.08B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
793.26 | 83.15B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
984.04 | 62.71B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
136.62 | 54.14B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
203.35 | 44.51B | 742.00K | -1.37B | -1.07B | -7.0731 |
Biovie Inc Stock (BIVI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2022-07-22 | Iniziato | Cantor Fitzgerald | Overweight |
| 2021-01-15 | Iniziato | B. Riley Securities | Buy |
Biovie Inc Borsa (BIVI) Ultime notizie
Biovie seeks FDA meeting to plan Phase 3 trial for Parkinson’s drug candidate - Parkinson's News Today
Jane Street Group Expands BioVie Inc (BIVI) Stake by Over 1,100% - GuruFocus
Market movers: Novartis, Qualcomm, EchoStar, BioVie... - proactiveinvestors.com
BioVie advances bezisterim Phase 3 Parkinson’s trial - grafa.com
BioVie advances Parkinson’s Phase 3 trial plans after positive Phase 2 results and FDA engagement. - Pluang
BioVie advances Parkinson’s Phase 3 development program with FDA engagement - Yahoo Finance
BioVie Announces Update to Parkinson’s Phase 3 Development Program - markets.businessinsider.com
Biovie Stock Price Forecast. Should You Buy BIVI? - StockInvest.us
Jane Street reports over 5% stake in BioVie (BIVI) - Stock Titan
Small cap wrap: Alvopetro, Royal Road Minerals, Nextech3D.ai, TNR Gold... - Proactive financial news
Market movers: PG&E, Aon, Eli Lilly, BioVie... - Proactive financial news
BioVie completes final patient visit in Phase 2 Long COVID trial, topline results due by September 2026 - Pluang
BioVie (BIVI) Completes Final Visit in ADDRESS-LC Phase 2 Trial for Long COVID Neurological Symptoms - GuruFocus
BioVie Announces Completion of Treatment Phase of - globenewswire.com
Dow falls as US strikes Iran, rate-hike bets jump - proactiveinvestors.co.uk
BioVie completes final patient visit in Phase 2 Long COVID trial - Proactive financial news
Price to earnings forward of BioVie Inc. – BOATS:BIVIW - TradingView
Biovie CFO Joanne Kim buys $5,450 in Biovie Inc. stock By Investing.com - Investing.com Australia
Insider Stock Purchases: August 29, 2026 - Moomoo
BioVie Stock (BIVI) Opinions on Phase 2 Trial Results - Quiver Quantitative
BioVie Inc. CEO Cuong V Do buys $31,636 in company stock - Investing.com India
Biovie director Amy Chappell acquires $1,570 in BIVI common stock By Investing.com - Investing.com India
BioVie Inc (BIVI) Chief Medical Officer Joseph Palumbo Buys 4,84 - GuruFocus
Biovie CMO Joseph Palumbo buys $10,460 in common stock By Investing.com - Investing.com Canada
BioVie (NASDAQ: BIVI) CMO boosts stake with open-market share buy - Stock Titan
Biovie CFO Joanne Kim buys $5,450 in Biovie Inc. stock - Investing.com
Biovie CMO Joseph Palumbo buys $10,460 in common stock - Investing.com
Anixa Biosciences Inc. (ANIX) Peer Comparison – Compare with Others - Value Research
BioVie (BIVI) Shares: Moves 9.74% Up to $2.14 in the Latest Session; Boundary Watch - vinanet.vn
BioVie (BIVI) Results at a Glance: EPS Prints Above Forecast in the Current Update; Stock Move: The Stock Ends Up 4.84% at the CloseEarnings Sentiment Score - vinanet.vn
Number of shareholders of BioVie Inc. – NASDAQ:BIVIW - TradingView
New to The Street Broadcasts Today Across Bloomberg Television U.S., Latin America and MENA at 6:30 PM ET - Newswire.com
BioVie (BIVIW) Trading: Records a 1.75% Decrease to $0.28 in the Latest Session; the Supplied Trading Band Runs From $0.27 to $0.29 on the DayIndex Put Call - vinanet.vn
BIVI Jumps As BioVie Reports Strong Parkinson’s Trial Data - StocksToTrade
BioVie Inc.Warrant (Nasdaq:BIVIW) Stock Quote - FinancialContent
BIVI Stock Pops As SUNRISE-PD Parkinson’s Data Fuel Hype - timothysykes.com
BioVie (BIVI) Jumps As SUNRISE-PD Data Fuel Bullish Hopes - StocksToTrade
Which stocks are moving before the opening bell on Friday? - ChartMill
12 Health Care Stocks Moving In Thursday's Intraday Session - Sahm
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Sahm
BioVie (BIVI) Financial Update: Profit Per Share Surpasses Its Benchmark in Latest Trading; Share Response: Shares Close 38.81% Higher on the DayWeak Earnings Momentum - vinanet.vn
MicroCaps IGC, BIVI, ORBS, RIME Sub-$1 Stocks to Watch Now - Barchart.com
BioVie (BIVI) Revenue BreakdownMain Composition - Moomoo
$BioVie (BIVI.US)$ told yall yesterday - Moomoo
BIVI Stock Draws Trader Focus After Strong Parkinson’s Data - StocksToTrade
BIVI Stock Draws Attention After Strong Parkinson’s Data - StocksToTrade
$BioVie (BIVI.US)$ Ready for lift off - Moomoo
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
New 8.4% BioVie (NASDAQ: BIVI) stake sits entirely in warrants - Stock Titan
BIVI Stock In Focus After SUNRISE-PD Trial Breakthrough - StocksToTrade
BIVI Stock Pops As Parkinson’s Drug Data Fuels Momentum - StocksToTrade
Biovie Inc Azioni (BIVI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):